Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|April 1, 2009
LA-419, a nitric-oxide donor for the treatment of cardiovascular disordersIan L Megson, Stephen J Leslie
Handbook of Experimental Pharmacology|December 18, 2008
NO and sGC-stimulating NO donorsIan L Megson, Mark R Miller
The Journal of Physiology|June 26, 2003
Nitric oxide and the mechanism of rat vascular smooth muscle photorelaxationFrederick Werner Flitney, Ian L Megson
Expert Opinion on Investigational Drugs|May 9, 2002
Nitric oxide donor drugs: current status and future trendsIan L Megson, David J Webb
Clinical Toxicology (Philadelphia, Pa.)|December 8, 2019
Does oxidative stress contribute to toxicity in acute organophosphorus poisoning? - a systematic review of the evidenceLekaashree Rambabu, Ian L Megson, Michael Eddleston
Food & Function|April 26, 2016
Lipids and cardiovascular disease: where does dietary intervention sit alongside statin therapy?Ian L Megson, Phillip D Whitfield, Ioannis Zabetakis
Expert Opinion on Therapeutic Targets|November 16, 2006
Therapeutic effects of nitric oxide-aspirin hybrid drugsCatriona M Turnbull, Adriano G Rossi, Ian L Megson
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 31, 2008
Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alphaSylwia Michlewska, Ian Dransfield, Ian L Megson, et al.
Pageof 11